David Erlinge
281 – 300 of 474
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Non-contact acoustic capture of platelet-derived microparticles from small plasma volumes
2015) 19th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2015 p.469-471(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
The effects of oxygen therapy on myocardial salvage in ST elevation myocardial infarction treated with acute percutaneous coronary intervention – The Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion (SOCCER) study
2015) The National Meeting in Emergency Medicine, 2015(
- Contribution to conference › Poster
-
Mark
Design of clinical cardioprotection trials using CMR : Impact of myocardial salvage index and a narrow inclusion window on sample size
(
- Contribution to journal › Published meeting abstract
-
Mark
The ATP Receptors P2X7 and P2X4 Modulate High Glucose and Palmitate-Induced Inflammatory Responses in Endothelial Cells.
(
- Contribution to journal › Article
- 2014
-
Mark
A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI.
(
- Contribution to journal › Article
-
Mark
Delay From First Medical Contact to Primary PCI and All-Cause Mortality: A Nationwide Study of Patients With ST-Elevation Myocardial Infarction.
(
- Contribution to journal › Article
-
Mark
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Regional wall function before and after acute myocardial infarction; an experimental study in pigs.
(
- Contribution to journal › Article
-
Mark
The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease
(
- Contribution to journal › Article
-
Mark
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.
(
- Contribution to journal › Article
-
Mark
Vascular smooth muscle cell proliferation depends on caveolin-1-regulated polyamine uptake
(
- Contribution to journal › Article
-
Mark
The enteric nervous system of P2Y13 receptor null mice is resistant against high-fat-diet- and palmitic-acid-induced neuronal loss.
(
- Contribution to journal › Article
-
Mark
Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients.
(
- Contribution to journal › Article
-
Mark
High-sensitivity troponin T as a diagnostic tool for acute coronary syndrome in the real world: an observational study.
(
- Contribution to journal › Article
-
Mark
Transient and rapid QRS widening associated with J-wave pattern predicts impending ventricular fibrillation in experimental myocardial infarction.
(
- Contribution to journal › Article
-
Mark
The brain-enriched microRNA miR-124 in plasma predicts neurological outcome after cardiac arrest
(
- Contribution to journal › Article
-
Mark
The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study.
(
- Contribution to journal › Article
-
Mark
Treatment Patterns and Outcomes in Patients Undergoing Percutaneous Coronary Intervention Treated With Prasugrel or Clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR])
(
- Contribution to journal › Article
-
Mark
Repeated epinephrine doses during prolonged cardiopulmonary resuscitation have limited effects on myocardial blood flow: a randomized porcine study
(
- Contribution to journal › Article
-
Mark
The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest: a post hoc analysis of the Target Temperature Management trial.
(
- Contribution to journal › Article